Atebrioz Tablet, Film Coated
Product Images NDC 79378-029

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atebrioz (NDC 79378-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mirum Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zilurgisertib Fumarate Dihydrate Chemical Structure (Atebrioz 1)

Chemical structure diagram of the active ingredient zilurgisertib, showing its molecular components including pyrimidine, phenyl, and other chemical groups with a hydrate (2 H2O) component.*

FDA Label Image

Atebrioz (zilurgisertib) Tablets 25 mg Label (Atebrioz 2)

Label for ATEBRIOZ (zilurgisertib) film coated tablets, 25 mg strength, with a package size of 120 tablets. The label includes dosage information, storage instructions, and states it is manufactured by Mirum Pharmaceuticals Inc. The NDC number 79378-029-16 is printed on the label along with a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.